Literature DB >> 15202051

Predictive factors for pancreatic cancer in patients with chronic pancreatitis in association with K-ras gene mutation.

M Arvanitakis1, J-L Van Laethem, J Parma, V De Maertelaer, M Delhaye, J Devière.   

Abstract

BACKGROUND AND STUDY AIMS: Chronic pancreatitis is considered to be a predisposing factor for pancreatic ductal adenocarcinoma (PAC). The purpose of this study was to examine the prognostic value of a finding of mutated (K- ras) gene in predicting the development of PAC in patients with chronic pancreatitis. PATIENTS AND METHODS: The pancreatic duct brushings of 146 patients with chronic pancreatitis were examined in order to identify K- ras gene mutations. A total of 112 patients were followed up (median duration 42 months) using clinical evaluation, serum CA19 - 9 levels, and imaging studies.
RESULTS: One or more K- ras mutations were found in 57 of the 146 patients with chronic pancreatitis (39 %). Patients harboring K- ras mutations had a higher incidence of persistent alcohol consumption ( P = 0.041) and of prior rupture of the main pancreatic duct ( P = 0.040). A finding of nuclear atypia in brushing cytology was also more common in patients with K- ras mutation ( P = 0.048). Out of the 112 patients who were followed up, PAC occurred in four of the 44 patients who had a K- ras mutation, but in none of the 68 patients with the wild genotype ( P = 0.022). PAC occurred in three of the 25 patients who did not have pancreatic calcifications ( P = 0.034) and in four of the 54 patients who had demonstrated exocrine insufficiency, but in none of the 58 patients with preserved exocrine function ( P = 0.051). Using stepwise logistic regression, the absence of calcifications, the presence of exocrine insufficiency, and the presence of K- ras mutation were identified as independent predictive factors for cancer development in all patients with chronic pancreatitis.
CONCLUSIONS: K- ras gene mutations occur in chronic pancreatitis and are associated with evolution towards PAC. The absence of pancreatic calcifications and the presence of exocrine insufficiency were identified as additional predictive factors for the development of PAC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15202051     DOI: 10.1055/s-2004-814401

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  18 in total

Review 1.  Emerging role of the KRAS-PDK1 axis in pancreatic cancer.

Authors:  Riccardo Ferro; Marco Falasca
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  Chronic pancreatic pain.

Authors:  Mannish Rungta
Journal:  MedGenMed       Date:  2005-01-24

Review 3.  Molecular markers of pancreatic cancer: development and clinical relevance.

Authors:  Lucia C Fry; Klaus Mönkemüller; Peter Malfertheiner
Journal:  Langenbecks Arch Surg       Date:  2008-02-12       Impact factor: 3.445

4.  Identification of biomarkers of human pancreatic adenocarcinomas by expression profiling and validation with gene expression analysis in endoscopic ultrasound-guided fine needle aspiration samples.

Authors:  Henrik Laurell; Michele Bouisson; Philippe Berthelemy; Philippe Rochaix; Sebastien Dejean; Philippe Besse; Christiane Susini; Lucien Pradayrol; Nicole Vaysse; Louis Buscail
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

5.  RETRACTED: Increased Ras GTPase activity is regulated by miRNAs that can be attenuated by CDF treatment in pancreatic cancer cells.

Authors:  Shadan Ali; Aamir Ahmad; Amro Aboukameel; Bin Bao; Subhash Padhye; Philip A Philip; Fazlul H Sarkar
Journal:  Cancer Lett       Date:  2012-01-17       Impact factor: 8.679

6.  Detection of K-ras gene mutations in feces by magnetic nanoprobe in patients with pancreatic cancer: A preliminary study.

Authors:  Xiaoguang Wang; Jingshuai Wang; Fei Chen; Zhengxiang Zhong; Lifeng Qi
Journal:  Exp Ther Med       Date:  2017-10-24       Impact factor: 2.447

7.  Evidence-based clinical practice guidelines for chronic pancreatitis 2015.

Authors:  Tetsuhide Ito; Hiroshi Ishiguro; Hirotaka Ohara; Terumi Kamisawa; Junichi Sakagami; Naohiro Sata; Yoshifumi Takeyama; Morihisa Hirota; Hiroyuki Miyakawa; Hisato Igarashi; Lingaku Lee; Takashi Fujiyama; Masayuki Hijioka; Keijiro Ueda; Yuichi Tachibana; Yoshio Sogame; Hiroaki Yasuda; Ryusuke Kato; Keisho Kataoka; Keiko Shiratori; Masanori Sugiyama; Kazuichi Okazaki; Shigeyuki Kawa; Yusuke Tando; Yoshikazu Kinoshita; Mamoru Watanabe; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2016-01-04       Impact factor: 7.527

Review 8.  Endoscopic management of complications of chronic pancreatitis.

Authors:  Jean-Marc Dumonceau; Carlos Macias-Gomez
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

9.  K-ras and Dpc4 mutations in chronic pancreatitis: case series.

Authors:  Marijana Popović Hadzija; Marina Korolija; Jasminka Jakić Razumović; Pajica Pavković; Mirko Hadzija; Sanja Kapitanović
Journal:  Croat Med J       Date:  2007-04       Impact factor: 1.351

Review 10.  Ras activity in acinar cells links chronic pancreatitis and pancreatic cancer.

Authors:  Craig D Logsdon; Baoan Ji
Journal:  Clin Gastroenterol Hepatol       Date:  2009-11       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.